CURIS, INC. Repayments of Debt
CURIS, INC. (CRIS) reported Repayments of Debt of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfDebt · last filed 2022-02-24
- CURIS, INC. repayments of debt for the quarter ending 2020-12-31 was $0.00.
- CURIS, INC. repayments of debt for the quarter ending 2020-09-30 was $0.00.
- CURIS, INC. repayments of debt for the quarter ending 2020-06-30 was $0.00.
- CURIS, INC. repayments of debt for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- CURIS, INC. repayments of debt for fiscal 2021 was $0.00.
- CURIS, INC. repayments of debt for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- CURIS, INC. repayments of debt for fiscal 2019 was $1.82M, a 70.10% decline from fiscal 2018.
- CURIS, INC. repayments of debt for fiscal 2018 was $6.10M, a 23.21% increase from fiscal 2017.
| Period end | Repayments of Debt 0 month | Repayments of Debt 1 month | Repayments of Debt 3 month | Repayments of Debt 3 month as first filed | Repayments of Debt 6 month | Repayments of Debt 6 month as first filed | Repayments of Debt 9 month | Repayments of Debt 9 month as first filed | Repayments of Debt 12 month | Repayments of Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-24 | |||||||||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 | ||||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $0.00 10-Q · filed 2020-11-10 | $0.00 derived: sum of 4 quarters · filed 2022-02-24 | ||||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $0.00 10-Q · filed 2020-08-04 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $0.00 derived: sum of 4 quarters · filed 2022-02-24 | ||||||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-12 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $0.00 derived: sum of 4 quarters · filed 2022-02-24 | ||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $1.82M 10-K · filed 2022-02-24 | ||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $1.82M 10-Q · filed 2020-11-10 | $3.50M derived: sum of 4 quarters · filed 2020-11-10 | ||||||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $1.82M 10-Q · filed 2020-08-04 | $3.50M derived: sum of 3 quarters · filed 2020-08-04 | $4.86M derived: sum of 4 quarters · filed 2020-08-04 | ||||||
| 2019-03-31 | $1.82M 10-Q · filed 2020-05-12 | $3.50M derived: sum of 2 quarters · filed 2020-05-12 | $4.86M derived: sum of 3 quarters · filed 2020-05-12 | $6.11M derived: sum of 4 quarters · filed 2020-05-12 | ||||||
| 2018-12-31 | $1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $3.03M derived: sum of 2 quarters · filed 2020-03-19 | $4.29M derived: sum of 3 quarters · filed 2020-03-19 | $6.10M 10-K · filed 2020-03-19 | ||||||
| 2018-09-30 | $1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | $2.62M derived: sum of 2 quarters · filed 2019-11-05 | $4.43M 10-Q · filed 2019-11-05 | $5.76M derived: sum of 4 quarters · filed 2019-11-05 | ||||||
| 2018-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $3.07M 10-Q · filed 2019-08-09 | $4.40M derived: sum of 3 quarters · filed 2019-08-09 | $5.42M derived: sum of 4 quarters · filed 2019-08-09 | ||||||
| 2018-03-31 | $1.81M 10-Q · filed 2019-05-14 | $3.14M derived: sum of 2 quarters · filed 2019-05-14 | $4.16M derived: sum of 3 quarters · filed 2019-05-14 | $5.09M derived: sum of 4 quarters · filed 2019-05-14 | ||||||
| 2017-12-31 | $1.33M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | $2.35M derived: sum of 2 quarters · filed 2019-03-26 | $3.28M derived: sum of 3 quarters · filed 2019-03-26 | $4.95M 10-K · filed 2019-03-26 | ||||||
| 2017-09-30 | $1.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $1.95M derived: sum of 2 quarters · filed 2018-11-01 | $3.63M 10-Q · filed 2018-11-01 | $4.68M derived: sum of 4 quarters · filed 2018-11-01 | ||||||
| 2017-06-30 | $931.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $2.61M 10-Q · filed 2018-08-02 | $3.66M derived: sum of 3 quarters · filed 2018-08-02 | $4.74M derived: sum of 4 quarters · filed 2018-08-02 | ||||||
| 2017-03-31 | $1.68M 10-Q · filed 2018-05-03 | $2.73M derived: sum of 2 quarters · filed 2018-05-03 | $3.81M derived: sum of 3 quarters · filed 2018-05-03 | $4.76M derived: sum of 4 quarters · filed 2018-05-03 | ||||||
| 2016-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $2.13M derived: sum of 2 quarters · filed 2018-03-08 | $3.08M derived: sum of 3 quarters · filed 2018-03-08 | $4.27M 10-K · filed 2018-03-08 | ||||||
| 2016-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $2.03M derived: sum of 2 quarters · filed 2017-11-07 | $3.22M 10-Q · filed 2017-11-07 | $4.59M derived: sum of 4 quarters · filed 2018-03-08 | ||||||
| 2016-06-30 | $950.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $2.14M 10-Q · filed 2017-08-03 | $3.51M derived: sum of 3 quarters · filed 2018-03-08 | $4.63M derived: sum of 4 quarters · filed 2018-03-08 | ||||||
| 2016-03-31 | $1.19M 10-Q · filed 2017-05-04 | $1.19M 10-Q · filed 2016-05-09 | $2.56M derived: sum of 2 quarters · filed 2018-03-08 | $3.68M derived: sum of 3 quarters · filed 2018-03-08 | $4.42M derived: sum of 4 quarters · filed 2018-03-08 | |||||
| 2015-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $2.49M derived: sum of 2 quarters · filed 2018-03-08 | $3.23M derived: sum of 3 quarters · filed 2018-03-08 | $4.16M 10-K · filed 2018-03-08 | $4.16M 10-K · filed 2016-02-29 | |||||
| 2015-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $1.86M derived: sum of 2 quarters · filed 2016-11-03 | $2.79M 10-Q · filed 2016-11-03 | $2.79M 10-Q · filed 2015-11-09 | $3.57M derived: sum of 4 quarters · filed 2017-03-09 | |||||
| 2015-06-30 | $747.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $1.68M 10-Q · filed 2016-08-04 | $1.68M 10-Q · filed 2015-08-06 | $2.45M derived: sum of 3 quarters · filed 2017-03-09 | $717.58K derived: sum of 4 quarters · filed 2017-03-09 | |||||
| 2015-03-31 | $929.34K 10-Q · filed 2016-05-09 | $1.77M 10-Q · filed 2015-05-07 | $1.70M derived: sum of 2 quarters · filed 2017-03-09 | -$30.08K derived: sum of 3 quarters · filed 2017-03-09 | $1.19M derived: sum of 4 quarters · filed 2017-03-09 | |||||
| 2014-12-31 | $773.19K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$959.42K derived: sum of 2 quarters · filed 2017-03-09 | $264.42K derived: sum of 3 quarters · filed 2017-03-09 | $1.59M 10-K · filed 2017-03-09 | $8.90M 10-K · filed 2015-02-24 | |||||
| 2014-09-30 | -$1.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$508.77K derived: sum of 2 quarters · filed 2015-11-09 | $813.81K 10-Q · filed 2015-11-09 | $4.28M 10-Q · filed 2014-11-10 | ||||||
| 2014-06-30 | $1.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $2.55M 10-Q · filed 2014-08-07 | ||||||||
| 2014-03-31 | $1.32M 10-Q · filed 2014-05-09 | |||||||||
| 2013-12-31 | $2.93M 10-K · filed 2014-03-13 | |||||||||
| 2013-08-30 | $765.00K 10-Q · filed 2013-11-12 | |||||||||
| 2013-05-31 | $631.19K 10-Q · filed 2013-11-12 | |||||||||
| 2013-03-06 | $531.88K 10-Q · filed 2013-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |